Benefits and cost effectiveness of nicotine replacement therapy - A decision making approach of direct medical costs;Nutzen und kosteneffektivität der nikotinersatztherapie zur raucherentwöhnung - Eine entscheidungsanalytische modellierung der direkten medizinischen kosten

Gesundheitsokonomie und Qualitatsmanagement

Volumn 13, Issue 2, 2008, Pages 99-108

  Wasem, Jürgen ^a   Jung, M ^b   May, U ^c   Ochotta, T ^d   Hessel, F ^a   Wegner, C ^e   Gutsch, A ^f   Neumann, A ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b BKK Bundesverband   (Germany)

^c Verband Forschender   (Germany)

^d University of Applied Sciecens   (Germany)

^e Niedersachsen   (Germany)

^f AOK Berlin ^*

Author keywords

Cost effectiveness; Life years gained; Nicotine replacement therapy; Smoking; Smoking related costs

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; GERMANY; GROUPS BY AGE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; NICOTINE REPLACEMENT THERAPY; PRODUCTIVITY; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; SMOKING CESSATION;

EID: 46949093045     PISSN: 14322625     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963541     Document Type: Article

References (34)

1. US-Department of Health and Human Services. Reducing the Health Consequences of Smoking, 25 Years of Progress. A Report of the Surgeon General, US-Department of Health and Human Services Public Health Service, Centres for Disease Control, Office on Smoking and Health, 1989; DHHS Publication No. (CDC) 89-8411
2. Doll R, Peto R, Wheatley K et al. Mortality in Relation to Smoking. 40 Years Observation on Mail British Doctors. British Medical Journal 1994; 309: 901-911
3. Ezzati M, Lopez AD. Estimates of Global Mortality Attributable to Smoking in 2000. Lancet 2003; 362: 847-852
4. John U, Hanke M. Tabakrauch-Attributable Mortalität in den deutschen Bundesländern. Gesundheitswesen 2001; 63: 363-369
5. Welte R, König HH, Leidel R. The Costs of Health Damage and Productivity Losses Attributable to Cigarette Smoking in Germany. €pean Journal of Public Health 2000; 10: 31-38
6. Peto R, Darby SC, Deo H et al. Smoking, Smoking Cessation, And Lung Cancer in the UK since 1950: Combination of National Statistics with two Case-Control Studies. British Medical Journal 2000; 321: 323-329
7. Wegner C, Gutsch A, Hessel F et al. Volkswirtschaftliche Produktionsverluste infolge des Rauchens - eine Analyse unter Berücksichtigung der Friktionskostenmethode. Gesundheitsökonomie & Qualitätsmanagement 2005; 10: 356-364 (zitiert als Wegner et al. 2005a)
8. Wegner C, Gutsch, Hessel F et al. Rauchen-attributale Produktivitätsausfallkosten in Deutschland-eine partielle Krankheitskostenstudie unter Zugrundelegung der Humankapitalmethode. Gesundheitswesen 2004; 64: 423-432
9. Rasmussen SR, Prescott E, SØrensen T et al. The total lifetime health cost savings of smoking cessation to society. €pean Journal of Public Health 2005; 6: 601-606
10. Wegner C, Gutsch A, Hessel F et al. Die Kosten der tabakbedingten Inanspruchnahme von Gesundheitsleistungen in Deutschland. Gesundheits- und Sozialpolitik 2005; 59, Heft 9-10: 34-41 (zitiert als: Wegner et al. 2005b)
11. Maynard A. Developing the Health Care Market. Economic Journal 1991; 101: 1277-1286
12. Silagy C et al. Nicotine-Replacement Therapy for Smoking Cessation. The Cochrane Library Oxford 2003; Issue 1: 1-79
13. Herrera N et al. A Doubleblind Placebo Control Trial within Behaviour Modification Support Programme. Cardiopulmonary and Critical Care Journal 1995; 108 (2): 447-451
14. Statistisches Bundesamt. Mikrozensus Wiesbaden, 2006
15. Batra A. Tabakabhängigkeit. Biologische und psychosoziale Entstehungsbedingungen und Therapiemöglichkeiten. Darmstadt: Dr. Dietrich Steinkopff Verlag, 2000: 28
16. Statistisches Bundesamt. Mikrozensus 2006
17. Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. London: NICE, 2002
18. Silagy C, Lancaster T, Stead L et al. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2004; Issue 3
19. IQWIG. Nikotinersatztherapie zur Raucherentwöhnung. www.gesundheitsinformation.de/merkblatt.102.222.de.html
20. Cochrane Review a.a.O.
21. Kawachi I, Colditz GA, Stampfer MJ et al. Smoking Cessation in Relation to Total Mortality Rates in Women: A prospective Cohort Study. Annals of Internal Medicine 1993; 119: 992-1000
22. Wegner et al. a.a.O.
23. Thun MJ, Myers DG, Day-Lally C et al. Age and the exposure-response relationships between cigarette smoking and premature death in Cancer Prevention Study II. Changes in cigarette-related disease risks and their implication for prevention and control. Nation Cancer Institute; Publication no. 97-1213: 282-305
24. US Department of Health and Human Serivices. Reducing Health Consequences of smoking. 25 years of progres. A report of the Surgeon General, US Department of Health and Human Services. Public Health Service, Centers fo Disease Control, Office on Smoking and Health, 1989; DHHS Publication Nr. (CDC) 89-8411
25. Wegner et al. Vgl. Tab. 1 und 3. 2005b
26. Wegner et al.. Vgl. Tab. 2. 2005b
27. I+G Infratest und GfK. Gesundheitsmarkt- und Pharmamarkt- Forschung. Sonderauswertung ACUTDatenbank. München, 1992
28. Statistisches Bundesamt. Diagnosedaten der Krankenhauspatienten. Stuttgart, 1999
29. Verband Deutscher Rentenversicherungsträger. VDR Statistik Rehabilitation des Jahres 1999 Frankfurt, 2000
30. Vgl. Kawachi et al. (1993); U.S. Department of Health and Human Services (1990a); U.S. Department of Health and Human Services (1990b); Rogot, Murray (1980); Doll, Peto et al. (1994); LaCroix et al. (1991); Rassmussen et al (2005).
31. Download der Satzarten 40 und 41 des Jahresausgleichs 2004 von der Homepage des Bundesversicherungsamtes. 2006. www.bundesversicherungsamt.de Link Fachinformationen - Risikostrukturausgleich - Jahresausgleiche - 2004
32. Vgl. etwa Gold et al. Cost-effectiveness in Health and Medicine. Oxford University Press. Oxford and New York. 1996
33. Woolacott et al. A rapid and systematic review of the clinical and cost effectiveness of bupropion SR and nicotine replacement therapy (NRT) for smoking cessation. NHS R&D HTA Programme. London, 2002:78
34. Handbuch Selbstmedikation. Berlin: Stiftung Warentest, 2006: 677 ff.